Sakar Healthcare Ltd vs Zim Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 19, 2026

Key Highlights

The Latest Trading Price of Sakar Healthcare Ltd is ₹ 779.95 as of 18 May 15:30 . The P/E Ratio of Sakar Healthcare Ltd changed from 16.5 on March 2021 to 26.6 on March 2025 . This represents a CAGR of 10.02% over 5 yearsThe P/E Ratio of Zim Laboratories Ltd changed from 16.1 on March 2021 to 32.1 on March 2025 . This represents a CAGR of 14.80% over 5 years The Market Cap of Sakar Healthcare Ltd changed from ₹ 176.64 crore on March 2021 to ₹ 464.72 crore on March 2025 . This represents a CAGR of 21.34% over 5 yearsThe Market Cap of Zim Laboratories Ltd changed from ₹ 117.75 crore on March 2021 to ₹ 390.78 crore on March 2025 . This represents a CAGR of 27.11% over 5 years The revenue of Sakar Healthcare Ltd for the Mar '26 is ₹ 71.27 crore as compare to the Dec '25 revenue of ₹ 70.85 crore. This represent the growth of 0.59% The revenue of Zim Laboratories Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 110.36 crore. This represent the decline of -100% The ebitda of Sakar Healthcare Ltd for the Mar '26 is ₹ 26.41 crore as compare to the Dec '25 ebitda of ₹ 19.1 crore. This represent the growth of 38.27% The ebitda of Zim Laboratories Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 14.51 crore. This represent the decline of -100% The net profit of Sakar Healthcare Ltd changed from ₹ 2.41 crore to ₹ 11.02 crore over 8 quarters. This represents a CAGR of 113.84% The net profit of Zim Laboratories Ltd changed from ₹ 0.9 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The Dividend Payout of Sakar Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Zim Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Sakar Healthcare Ltd

Sakar Healthcare Limited was incorporated as a Private Limited Company under the name 'Sakar Healthcare Private Limited on 26th March 2004.
Subsequently, the Company was converted into Public Limited Company on March 27, 2015 and the name of the Company was changed to 'Sakar Healthcare Limited.
The Company is promoted by Sanjay Shah, Rita Shah and Aarsh Shah. The Company is engaged in manufacturing of Pharmaceutical products providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Dry Powder Injections, Liquid Injectables (SVP) in Ampoules and Vials & Lyophilized Injections and Oral Solid Dossages.
It manufactures and markets pharmaceutical formulations relating to analgesics, anti coagulants, anti malarial, anti spasmodic, antianemics, antibiotics, anti-emetics, anti-histamines, bronchodilators, corticosteroids, cough and cold preparations, multivitamins, etc.

About Zim Laboratories Ltd

Zim Laboratories Limited was incorporated in February, 1984 under the name and style of Zim Laboratories Private Limited in Maharashtra.
The Company became a Public Limited Company through fresh Certificate of Incorporation issued by the Registrar of Companies, Mumbai.
The Company is engaged in the manufacturing of formulation on drugs and pre formulation ingredients in India and marketing and selling these within and outside India.
The Pharma Industry is dominated by Multinationals, Large Indian companies and in the lower end of the market large number of units mainly in the SSI sector. During the year 2019-20, ZIM Health Technologies Limited was acquired, making it a wholly owned subsidiary of the Company.
SIA ZIM Laboratories Limited got incorporated as a wholly owned subsidiary in Latvia.

FAQs for the comparison of Sakar Healthcare Ltd and Zim Laboratories Ltd

Which company has a larger market capitalization, Sakar Healthcare Ltd or Zim Laboratories Ltd?

Market cap of Sakar Healthcare Ltd is 1,735 Cr while Market cap of Zim Laboratories Ltd is 514 Cr

What are the key factors driving the stock performance of Sakar Healthcare Ltd and Zim Laboratories Ltd?

The stock performance of Sakar Healthcare Ltd and Zim Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sakar Healthcare Ltd and Zim Laboratories Ltd?

As of May 19, 2026, the Sakar Healthcare Ltd stock price is INR ₹779.95. On the other hand, Zim Laboratories Ltd stock price is INR ₹96.0.

How do dividend payouts of Sakar Healthcare Ltd and Zim Laboratories Ltd compare?

To compare the dividend payouts of Sakar Healthcare Ltd and Zim Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.